Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
株式のランク #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
株価
$0.83030862
最終同期: 2024-06-27
時価総額
$726.64K
変化(1日)
-1.35%
変化(1年)
0.00%
DE
取引 Epigenomics AG (ECX)

カテゴリー

Epigenomics AG(ECX)の株価履歴
終値の最高値: $1.42 (2024-06-01)

終値の最安値: $761.72 (2014-09-01)
Epigenomics AG の株価履歴(2014 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2024 -40.31%
2023 -70.25%
2022 -39.44%
2021 -83.30%
2020 -68.68%
2019 -24.83%
2018 -54.25%
2017 -3.39%
2016 90.76%
2015 -58.46%
2014 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$592.13 22.08%
US
$203.44 -3.23%
US
$23.08 67.91%
CN
$310.78 96.15%
US
$560.26 -14.33%
US